Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03818503
Other study ID # EORTC-1811
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date June 24, 2019
Est. completion date April 30, 2024

Study information

Verified date April 2023
Source European Organisation for Research and Treatment of Cancer - EORTC
Contact EORTC HQ
Phone +32 2 774 1611
Email 1811@eortc.org
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

The primary objective is the collection of real-world data of cancer patients treated with radiotherapy, to support radiotherapy research and to provide evidence of the role of radiation oncology in a multidisciplinary approach. This is an open ended prospective non-interventional non-therapeutic multi-cohort study.


Recruitment information / eligibility

Status Recruiting
Enrollment 2000
Est. completion date April 30, 2024
Est. primary completion date April 30, 2024
Accepts healthy volunteers
Gender All
Age group 12 Years and older
Eligibility Inclusion Criteria: - Pathologically confirmed cancer. - Written informed consent for E²-RADIatE according to applicable legal and ethical requirements - Planned use of radiotherapy - Eligibility of the patient confirmed for at least one cohort confirmed - Patients of 12 years and older

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Austria Medical University of Graz - Radio-oncology Graz
Austria Ordensklinikum Linz-Barmherzige Schwestern Linz
Austria Universitaetskliniken der Uni Wien - Universitaetsklinikum Wien - AKH unikliniken Vienna
Belgium Onze Lieve Vrouw Ziekenhuis Aalst
Belgium Cliniques Universitaires Saint-Luc Brussels
Belgium Universitair Ziekenhuis Gent Gent
Belgium AZ Groeninge Kortrijk - Campus Kennedylaan Kortrijk
Belgium U.Z. Leuven - Campus Gasthuisberg Leuven
Belgium CHU Site Sainte-Elisabeth-UCL Namur Namur
Belgium AZ Turnhout - Campus Sint Elisabeth Turnhout
Belgium GasthuisZusters Antwerpen - Sint-Augustinus Wilrijk
Czechia University Hospital Hradec Kralove Hradec Kralove
France Clinique Pasteur-Lanroze (1174) Brest
Germany Universitaetsklinikum Aachen AOR - Medizinische Fakultaet der RWTH Aachen
Germany Klinikum Bayreuth Gmbh Bayreuth
Germany Universitaetsklinikum Carl Gustav Carus Dresden
Italy Ospedale S. Donato, USL -8 Arezzo
Italy Azienda Ospedaliero-Universitaria Careggi Firenze
Italy Istituto Clinico Humanitas Milan
Italy IRCCS Ospedale San Raffaele Milano
Italy Istituto Europeo di Oncologia Milano
Italy Sacro Cuore Hospital Negrar
Italy Centro Nazionale di Adroterapia Oncoloica par il trattamento dei tumori Pavia
Italy Istituti Clinici Scientifici Maugeri Pavia
Italy Policlinico Universitario Campus Bio-Medico- Oncology Center Roma
Italy Universita Di Torino Torino
Netherlands Stichting Catharina Ziekenhuis Eindhoven
Netherlands Radboudumc - Radboud University Medical Center Nijmegen Nijmegen
Netherlands Radiotherapiegroep Arnhem Nijmegen
Slovenia The Institute Of Oncology Ljubljana
Spain ICO Badalona - Hospital Germans Trias i Pujol (Institut Catala D'Oncologia) Badalona
Spain Hospital De La Santa Creu I Sant Pau Barcelona
Spain Hospital Universitari Vall d'Hebron -Vall d'Hebron Institut Oncologia Barcelona
Spain Hospital General Universitario Santa Lucia Cartagena
Spain Hospital Universitario Reina Sofia Cordoba
Spain Hospital Universitario de La Princesa Madrid
Spain Hospital Universitario San Carlos Madrid
Spain Complejo Hospitalario de Navarra Pamplona
Spain Hospital Universitario de Salamanca (430) Salamanca
Spain Hospital Universitario La Fe Valencia
Switzerland Inselspital Bern
Switzerland Hôpitaux universitaires de Genève - HUG - site de Cluse-Roseraie Geneve
Switzerland Reseau Hospitalier Neuchatelois - RHNe - La Chaux de Fonds La Chaux-de-Fonds
Switzerland Hopital du Valais - Hopital de Sion Sion
Switzerland UniversitaetsSpital Zurich Zürich
United Kingdom NHS Grampian - Aberdeen Royal Infirmary Aberdeen
United Kingdom The Christie NHS Foundation trust - The Christie NHS Foundation Trust Manchester
United Kingdom Sheffield Teaching Hospitals NHS Foundation Trust - Weston Park Hospital Sheffield

Sponsors (1)

Lead Sponsor Collaborator
European Organisation for Research and Treatment of Cancer - EORTC

Countries where clinical trial is conducted

Austria,  Belgium,  Czechia,  France,  Germany,  Italy,  Netherlands,  Slovenia,  Spain,  Switzerland,  United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of patients treated with radiotherapy enrolled in the program 5 years
Secondary Disease free survival 5 years
Secondary Loco-regional control 5 years
Secondary Distant metastasis free survival 5 years
Secondary Overall survival 5 years
Secondary Incidence of adverse events related to radiotherapy 5 years
See also
  Status Clinical Trial Phase
Recruiting NCT05346796 - Survivorship Plan HEalth REcord (SPHERE) Implementation Trial N/A
Recruiting NCT05094804 - A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents Phase 1/Phase 2
Completed NCT04867850 - Effect of Behavioral Nudges on Serious Illness Conversation Documentation N/A
Enrolling by invitation NCT04086251 - Remote Electronic Patient Monitoring in Oncology Patients N/A
Completed NCT01285037 - A Study of LY2801653 in Advanced Cancer Phase 1
Completed NCT00680992 - Study of Denosumab in Subjects With Giant Cell Tumor of Bone Phase 2
Completed NCT00062842 - Study of Irinotecan on a Weekly Schedule in Children Phase 1
Active, not recruiting NCT04548063 - Consent Forms in Cancer Research: Examining the Effect of Length on Readability N/A
Completed NCT04337203 - Shared Healthcare Actions and Reflections Electronic Systems in Survivorship N/A
Recruiting NCT04349293 - Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways N/A
Terminated NCT02866851 - Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy N/A
Active, not recruiting NCT05304988 - Development and Validation of the EFT for Adolescents With Cancer
Completed NCT00340522 - Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Active, not recruiting NCT03844048 - An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial Phase 3
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Completed NCT03109041 - Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source Phase 1
Terminated NCT01441115 - ECI301 and Radiation for Advanced or Metastatic Cancer Phase 1
Recruiting NCT06206785 - Resting Energy Expenditure in Palliative Cancer Patients
Recruiting NCT05318196 - Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases